REFI Q1 2026 Earnings Transcript

Chicago Atlantic reported $13.1 million of net interest income, down 8% sequentially, while loan portfolio principal was $414 million across 25 companies and weighted average yield to maturity declined to 15.8% from 16.3%. Credit quality was mixed: nonaccruals fell to 4.8% from 11.1% after loan #9 returned to accrual, but risk-rated 4+ loans rose to 10.7% and the CECL reserve increased $3.8 million to $8.7 million. Management highlighted the DOJ’s Schedule III rescheduling of medical marijuana as a credit-positive catalyst, maintained a 90%-100% payout target, and signaled a possible special dividend in Q4.

Analysis

The market is likely underestimating how much of REFI’s earnings durability now comes from structure, not just borrower health. With most loans floored and only a small slice still exposed to further base-rate declines, the usual REIT “lower-for-longer” headwind is largely muted; that makes book value and dividend coverage more resilient than headline floating-rate exposure suggests. The flip side is that upside from policy easing is now capped, so the stock should trade less like a rate play and more like a credit-selection vehicle with a policy beta overlay.

The bigger second-order winner from Schedule III is not REFI alone but the highest-quality operators that can refinance away from expensive private credit. That is a near-term negative for spread capture if good borrowers accelerate repayments, but a medium-term positive for REFI’s credit book because the marginal borrower pool improves as weaker balance sheets exit the market. In other words, faster prepayments can be value-accretive if they recycle capital into better collateral and lower loss content, especially given the company’s emphasis on real-estate-backed originations.

The true risk is not the regulation headline; it is that the reserve build may prove only the first step if Illinois and Arizona continue to deteriorate faster than the underwriting assumed. The current reserve increase and risk-rating migration signal that credit dispersion is widening, and in this niche lender the market usually lags the loan book by 1-2 quarters before sentiment adjusts. If rescheduling optimism lifts multiples across cannabis names without immediately improving cash conversion, REFI could face the classic trap: better equity valuations for borrowers, but not enough realized cash flow improvement to prevent additional CECL pressure.

Consensus is probably too linear on the regulatory catalyst. The most important near-term variable is not whether medical 280E relief happens, but whether lenders can use the improved backdrop to force restructurings, add equity, or take control of assets before the broader market rerates those same assets. That creates a narrow but potentially attractive window where REFI’s workout expertise can convert what looks like problem credit into mark-to-market upside over the next 2-3 quarters.

Key Decisions for Investors

• Long REFI common or call spreads into the next 1-2 quarters if you believe Schedule III-driven cash flow improvement will reduce realized losses before CECL catches up; target a rerating toward book value, with downside capped by dividend support but risk of another reserve build.
• Use a pair trade: long REFI / short a more rate-sensitive mREIT basket (e.g., NLY, AGNC) over 3-6 months; REFI has far less exposure to further cuts and more idiosyncratic policy upside, while agency REITs remain structurally exposed to duration and prepayment noise.
• Hedge the credit tail by buying REFI downside puts or a put spread ahead of the June-July administrative hearing; this is a binary-vol event where policy optimism can mask loan-specific deterioration for 1-2 quarters.
• Add exposure only on weakness after any CECL-driven selloff, not on strength after regulatory headlines; the better entry is when the market prices in policy disappointment while the loan book still benefits from improved refinancing optionality.
• If seeking relative value in cannabis, pair long REFI against a high-beta cannabis equity basket; REFI is the cleaner way to express improving industry fundamentals because it monetizes the sector through contractual cash flow rather than operating leverage.